Review Article | Volume: 12, Issue: 8, August, 2022

Two years of the pandemic: Impact of COVID-19 on tuberculosis management in Nigeria

Amarachi Ruth Anigbo Lokesh Gambhir   

Open Access   

Published:  Aug 04, 2022

DOI: 10.7324/JAPS.2022.120801

Tuberculosis case recognition and plotting is a key strategy employed by the National Tuberculosis and Leprosy Control Program in Nigeria to curtail the increasing gap of tuberculosis cases. Nigeria recorded its first case of COVID-19 in late January 2020, and since then Nigeria has currently recorded 255,753 confirmed cases with 3,143 deaths. It has currently recorded 2,699 new cases, as of 2 May 2022, among tuberculosis patients. Since the emergence of coronavirus, there has been a progressive decrease in clinic attendance and tuberculosis identification, detection, mapping, and management. The COVID-19 pandemic has impacted negatively on tuberculosis patients’ services in Nigeria as well as the nutritional status of tuberculosis patients. The present review summarizes the impact of COVID19 on the tuberculosis epidemic in Nigeria. The tuberculosis program could maximize potential resources employed to combat the pandemic, such as digital health technology and funds, and work toward strengthening the patient-centered approach of care to limit the challenges that COVID-19 presents to tuberculosis control.

Keyword:     Tuberculosis COVID-19 nutrition Nigeria epidemiology


Anigbo AR, Gambhir L. Two years of the pandemic: Impact of COVID-19 on tuberculosis management in Nigeria. J Appl Pharm Sci, 2022; 12(08):001–008.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Amanze E, Obiora O, Chibuzo E. Nigerian budgetary response to the COVID-19 pandemic and its shrinking fiscal space: financial sustainability, employment, social inequality and business implications. J Public Budg Account Financ Manag, 2020; 32(5):919-28.

Bartzatt R. Tuberculosis infections of the central nervous system. Cent Nerv Syst Agents Med Chem, 2011; 11(4):321-7.

Bhagya S, Thomas ETA, Sasidharan PK. Tuberculosis control in India: refocus on nutrition. Ind J of Tuber, 2018; 66(1):26-9.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010; 363(11):1005-15.

Bonadonna LV, Saunders MJ, Zegarra R, Evans C, Alegria-Flores K, Guio H. Why Wait? The social determinants underlying tuberculosis diagnostic delay. PLoS One, 2017; 12(9):0185018.

Brandt A, Botelho A. Not a perfect storm - COVID-19 and the importance of language. N Engl J Med, 2020; (382):1493-5.

Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls, 2022; 1(05): 001-123.

Carter DJ, Glaziou P, Lönnroth K, Siroka A, Floyd K, Weil D, Raviglione M, Houben RMGJ, Boccia D. The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of sustainable development goal 1. Lancet Glob Health, 2018; 6(5):514-22.

Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PDMC, Bulabula ANH, Sam-Agudu NA, Nachega JB, Tiberi S, McHugh TD, Abubakar I, Zumla A. Global Tuberculosis report 2020-reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis, 2021; 113:S7-12.

Chalmers JD, Crichton ML, Goeminne PC, Cao B, Humbert M, Shteinberg M, Antoniou KM, Ulrik CS, Parks H, Wang C, Vandendriessche T, Qu J, Stolz D, Brightling C, Welte T, Aliberti S, Simonds AK, Tonia T, Roche N. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J, 2021; 57(4):2100048. Published 2021 Apr 15.

Cherian A, Thomas SV. Central nervous system tuberculosis. Afr Health Sci, 2011; 11(1):116-27. PMID: 21572867; PMCID: PMC3092316.

COVID-19: looming crisis in developing countries threatens to devastate economies and ramp up inequality. United Nations Development Programme, New York, NY, 2021.

Cox V, Wilkinson L, Grimsrud A, Cox V, Wilkinson L, Grimsrud A, Hughes J, Reuter A, Conradie F, Nel J, Boyles T. Critical changes to services for TB patients during the COVID-19 pandemic. Int J Tuberc Lung Dis, 2020; (3):542-4.

Dan-Nwafor C, Ochu CL, Elimian K, Oladejo J, Ilori E, Umeokonkwo C, Steinhardt L, Igumbor E, Wagai J, Okwor T, Aderinola O, Mba N, Hassan A, Dalhat M, Jinadu K, Badaru S, Arinze C, Jafiya A, Disu Y, Saleh F, Abubakar A, Obiekea C, Yinka-Ogunleye A, Naidoo D, Namara G, Muhammad S, Ipadeola O, Ofoegbunam C, Ogunbode O, Akatobi C, Alagi M, Yashe R, Crawford E, Okunromade O, Aniaku E, Mba S, Agogo E, Olugbile M, Eneh C, Ahumibe A, Nwachukwu W, Ibekwe P, Adejoro OO, Ukponu W, Olayinka A, Okudo I, Aruna O, Yusuf F, Alex-Okoh M, Fawole T, Alaka A, Muntari H, Yennan S, Atteh R, Balogun M, Waziri N, Ogunniyi A, Ebhodaghe B, Lokossou V, Abudulaziz M, Adebiyi B, Abayomi A, Abudus-Salam I, Omilabu S, Lawal L, Kawu M, Muhammad B, Tsanyawa A, Soyinka F, Coker T, Alabi O, Joannis T, Dalhatu I, Swaminathan M, Salako B, Abubakar I, Fiona B, Nguku P, Aliyu SH, Ihekweazu C. Nigeria's public health response to the COVID-19 pandemic: January to May 2020. J Glob Health, 2020; 10(2):020399.

Datta S, Gilman RH, Montoya R, Quevedo Cruz L, Valencia T, Huff D, Saunders MJ, Evans CA. Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study. Eur Respir J, 2020;56(2):1900495.

Datta S, Saunders MJ, Tovar MA, Evans CA. Improving tuberculosis diagnosis: better tests or better healthcare? PLoS Med, 2017; 14(10):1002406.

Datta S, Evans CA. Healthy survival after tuberculosis. Lancet Infect Dis, 2019; 19(10):1045-7.

Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest, 2012;142(1):63-75.

Dye C. After 2015: infectious diseases in a new era of health and development. Phil Trans B Bio Sci, 2014; 369(1645):20130426.

Dye C, Lönnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Org, 2009; 87(9):683-91.

Ejiogu A, Okechukwu O, Ejiogu C. Nigerian budgetary response to the COVID-19 pandemic and its shrinking fiscal space: financial sustainability, employment, social inequality and business implications. J Public Budg Account Financ Manage, 2020;32(5):919-28.

Gao Y, Liu M, Chen Y, Shi S, Geng J, Tian J. Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis. J Med Virol, 2020; 93(1):194-6.

González-Domenech CM, Pérez-Hernández I, Gómez-Ayerbe C, Viciana Ramos I, Palacios-Muñoz R, Santos J. A Pandemic within other pandemics. when a multiple infection of a host occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis. Viruses, 2021; 13(5):931.

Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health, 2020; 8(9): e1132-41.

Hussien B, Ameni G. A Cross-sectional study on the magnitude of undernutrition in Tuberculosis patients in the Oromia Region of Ethiopia. J Multidiscip Healthc, 2021; 2(14):2421-8.

Jeremiah C, Mishal K, Francine N, Eleni A, Razia F, Peter M, Nathan K, Sayoki M, Seyed EH, Patrick DMCK, André NHB, Nadia AS, Jean BN, Simon T, Timothy DMH, Ibrahim A, Alimuddin Z. Global Tuberculosis Report 2020 reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis, 2021.

Krishna BG, Rajesh G, Atulya A, Manish V, Suman V. Tuberculosis and nutrition. Lung Ind, 2009; 26(1):9-16.

Lauretani F, Ravazzoni G, Roberti MF, Longobucco Y, Adorni E, Grossi M, De Iorio A, La Porta U, Fazio C, Gallini E, Federici R, Salvi M, Ciarrocchi E, Rossi F, Bergamin M, Bussolati G, Grieco I, Broccoli F, Zucchini I, Ielo G, Morganti S, Artoni A, Arisi A, Tagliaferri S, Maggio M. Assessment and treatment of older individuals with COVID 19 multisystem disease: Clinical and ethical implications. Acta Biomed, 2020; 91(2):150-68.

Mandal N, De N, Jana P, Sannigrahi A, Chattopadhyay K. Correlation between CNS Tuberculosis and the COVID-19 pandemic: the neurological and therapeutic insights. ACS Chem Neurosci, 2020; 11(18):2789-92.

Matthew JS, Carlton AE. COVID-19, Tuberculosis and poverty: preventing a perfect storm. Euro Res J, 2020; 56(1):2001348.

Menzies D, Fanning A, Yuan L, FitzGerald JM. Hospital ventilation and risk for tuberculous infection in canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Ann Intern Med, 2000; 133(10):779-89.

Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J, 2012; 3(1):2-6.

Nyendak MR, Lewinsohn DA, Lewinsohn DM. New diagnostic methods for tuberculosis. Curr Opin Infect Dis, 2009; 22(2):174-82.

National Centre for Disease Control (NCDC), 2022. Available via OECD. Developing countries and development co-operation: what is at stake, 2021. Available via policy-responses/developing-countries-and-development-co-operationwhat-is-at-stake-50e97915/.

Ogbuabor DC, Onwujekwe OE. Governance of tuberculosis control programme in Nigeria. Infect Dis Poverty, 2019; 8(1):45.

Oladimeji O, Adepoju V, Anyiam FE, San JE, Odugbemi BA, Hyera FLM, Sibiya MN, Yaya S, Zoakah AI, Lawson L. Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria. PLoS One, 2021; 16(1):e0244581.

Paul A. Nigeria's widening tuberculosis gap. Lancet Infect Dis, 2020; 20(1):29.

Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genom, 2020; 52(11):549-57.

Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet, 2015; 386(10010):2344-53.

Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lönnroth K, Barreira D, Boccia D. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: an economic modelling study. PLoS Med, 2017; 14(11):1002418.

Sampson EA, Theresa A, Joseph RO. Evaluation of the burden and intervention strategies of TB-HIV co-infection in West Africa. J Infect Dis Epidemiol, 2020; 6(4).

Saunders MJ, Evans CA. Fighting poverty to prevent tuberculosis. Lancet Infect Dis, 2016; 16(4):395-6.

Saunders MJ, Tovar MA, Collier D, Baldwin MR, Montoya R, Valencia TR, Gilman RH, Evans CA. Active and passive case-finding in tuberculosis-affected households in peru: a 10-year prospective cohort study. Lancet Infect Dis, 2019; 19(5):519-28.

Saunders MJ, Wingfield T, Datta S, Montoya R, Ramos E, Baldwin BMR, Tocvar MA, Evans BEW, Gilman RH, Evans CA. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infect Dis, 2020; 20(1):110-22.

Saunders MJ, Wingfield T, Tovar MA, Baldwin MR, Datta S, Zevallos K, Montoya R, Valencia TR, Friedland JS, Moulton LH, Gilman RH, Evans CA. A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study. Lancet Infect Dis, 2017; 17(11):1190-9.

Saunders MJ, Wingfield T, Tovar MA, Herlihy N, Rocha C, Zevallos K, Montoya R, Ramos E, Datta S, Evans CA. Mobile phone interventions for tuberculosis should ensure access to mobile phones to enhance equity ′ a prospective, observational cohort study in Peruvian Shantytowns. Trop Med Int Health, 2018; 23(8):850-9.

Siroka A, Ponce NA, Lönnroth K. Association between spending on social protection and tuberculosis burden: a global analysis. Lancet Infect Dis, 2016; 16(4):473-9.

Sumner A, Hoy C, Ortiz-Juarez E. Estimates of the impact of COVID-19 on global poverty (Wider Working Paper 2020/43).

World Institute for Development Economic Research (UNU-WIDER), Helesinki, Finland, 2020.

Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, Andréjak C, Bachez P, Bart PA, Belilovski E, Cardoso-Landivar J, Centis R, D'Ambrosio L, Luiza De Souza-Galvão M, Dominguez-Castellano A, Dourmane S, Fréchet Jachym M, Froissart A, Giacomet V, Goletti D, Grard S, Gualano G, Izadifar A, Le Du D, Marín Royo M, Mazza-Stalder J, Motta I, Ong CWM, Palmieri F, Rivière F, Rodrigo T, Silva DR, Sánchez-Montalvá A, Saporiti M, Scarpellini P, Schlemmer F, Spanevello A, Sumarokova E, Tabernero E, Tambyah PA, Tiberi S, Torre A, Visca D, Zabaleta Murguiondo M, Sotgiu G, Migliori GB. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Euro Res J, 2020; 56(1):2001398.

TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort [published online ahead of print, 2021 Nov 11]. Eur Respir J, 2021; 2102538.

World Health Organization. Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. World Health Organization, Geneva, Switzerland, 2007 (WHO/HTM/TB/2007.379).

WHO. More than half a billion people pushed or pushed further into extreme poverty due to healthcare cost, 2021. news/item/12-12-2021-more-than-half-a-billion-people-pushed-or-pushedfurther-into-extreme-poverty-due-to-health-care-costs Accessed 5/02/2022.

Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, Datta S, Saunders MJ, Lewis JJ, Gilman RH, Evans CA. A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru. Bull World Health Org, 2017; 95(4):270-80.

Wingfield T, Boccia D, Tovar MA, Gavino A, Zevallos K, Montoya R, Lönnroth K, Lönnroth K. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multidrug resistance: a prospective cohort study, Peru. PLoS Med, 2014; 11(7):1001675.

Wingfield T, Boccia D, Tovar MA, Huff D, Montoya R, Lewis JJ, Gilman RH, Evans CA. Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru. BMC Public Health, 2015; (15):810-9.

Wingfield T, Tovar MA, Datta S, Saunders MJ, Evans CA. Addressing social determinants to end tuberculosis. Lancet, 2018; 391(10126):1129-32.

Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, Lewis JJ, Gilman RH, Evans CA. The economic effects of supporting tuberculosis-affected households in Peru. Euro Res J, 2016; 48(5): 1396-410.

World Health Organization. Global tuberculosis report 2019, World Health Organization, Geneva, Switzerland, 2019.

Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, Zhao Y, Keshavjee S, Becerra MC. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. Lancet, 2015; 386(10010):2334-43.

Article Metrics

1 Absract views 1 PDF Downloads 2 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required